PAVmed Inc. operates as a medical device company in the United States. The company’s product pipeline includes NextFlo, a disposable infusion pump; PortIO, a long-term implantable vascular access device; Caldus, a disposable tissue ablation device; CarpX, a percutaneous device to treat carpal tunnel syndrome; and NextCath, a self-anchoring short-term catheter. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is headquartered in New York, New York.
Type
Public
HQ
Queens, US
Founded
2014
Employees
2 (est)
PAVmed was founded in 2014 and is headquartered in Queens, US

PAVmed Locations

Queens, US

PAVmed Metrics

PAVmed Summary

Market capitalization

$106 M

Closing share price

$8
PAVmed's latest market capitalization is $106 M.

PAVmed Market Value History

PAVmed News

PAVmed Company Life

You may also be interested in